Edwards Lifesciences | EW - Selling And Administration Expenses

Stock Price
80.08
Daily Change
0.58 0.73%
Monthly
-8.14%
Yearly
11.42%
Q2 Forecast
76.96

Edwards Lifesciences reported $602.9M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 78.34M 109K Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Masimo USD 128M 11.6M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025